vimarsana.com
Home
Live Updates
Findings of a Phase III Clinical Study of Sanbexin® Sublingual Tablets Published in JAMA : vimarsana.com
Findings of a Phase III Clinical Study of Sanbexin® Sublingual Tablets Published in JAMA : vimarsana.com
Findings of a Phase III Clinical Study of Sanbexin® Sublingual Tablets Published in JAMA
/PRNewswire/ -- On February 19, 2024, the Journal of American Medical Association•Neurology (JAMA NEUROLOGY, IF: 29.0) published online the key findings of a...
Related Keywords
Nanjing ,
Jiangsu ,
China ,
United States ,
Dongsheng ,
Jilin ,
Peking ,
Beijing ,
American ,
Wang Yongjun ,
Neurodawn Pharmaceutical Co Ltd ,
Simcere Pharmaceutical Group ,
Tiantan Hospital Of Capital Medical University ,
National Medical Products Administration Of China ,
Simcere Pharmaceutical Group Ltd ,
University Third Hospital ,
Journal Of American Medical Association ,
American Medical Association ,
Dexborneol Concentrated Solution ,
New Drug Application ,
National Medical Products Administration ,
Beijing Tiantan Hospital ,
Capital Medical University ,
Fan Dongsheng ,
Peking University Third Hospital ,
Pharmaceutical Group ,
Simcere Pharmaceutical Group Limited ,
Pharmaceuticals ,
Health Care Amp Hospitals ,
Medical Pharmaceuticals ,
Biotechnology ,
Clinical Trials Amp Medical Discoveries ,